148 related articles for article (PubMed ID: 35209922)
1. MR-guided radiotherapy in node-positive non-small cell lung cancer and severely limited pulmonary reserve: a report proposing a new clinical pathway for the management of high-risk patients.
Eze C; Lombardo E; Nierer L; Xiong Y; Niyazi M; Belka C; Manapov F; Corradini S
Radiat Oncol; 2022 Feb; 17(1):43. PubMed ID: 35209922
[TBL] [Abstract][Full Text] [Related]
2. Initial report on feasibility of PET/CT-based image-guided moderate hypofractionated thoracic irradiation in node-positive non-small cell lung Cancer patients with poor prognostic factors and strongly diminished lung function: a retrospective analysis.
Eze C; Taugner J; Roengvoraphoj O; Schmidt-Hegemann NS; Käsmann L; Wijaya C; Belka C; Manapov F
Radiat Oncol; 2019 Sep; 14(1):163. PubMed ID: 31484542
[TBL] [Abstract][Full Text] [Related]
3. Pooled analysis on image-guided moderately hypofractionated thoracic irradiation in inoperable node-positive/recurrent patients with non-small cell lung cancer with poor prognostic factors and severely limited pulmonary function and reserve.
Eze C; Guggenberger JE; Schmidt-Hegemann NS; Kenndoff S; Taugner J; Käsmann L; Schönecker S; Flörsch B; Li M; Belka C; Manapov F
Cancer; 2022 Jun; 128(12):2358-2366. PubMed ID: 35417563
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary magnetic resonance-guided online adaptive radiotherapy of locally advanced: the PUMA trial.
Regnery S; de Colle C; Eze C; Corradini S; Thieke C; Sedlaczek O; Schlemmer HP; Dinkel J; Seith F; Kopp-Schneider A; Gillmann C; Renkamp CK; Landry G; Thorwarth D; Zips D; Belka C; Jäkel O; Debus J; Hörner-Rieber J
Radiat Oncol; 2023 May; 18(1):74. PubMed ID: 37143154
[TBL] [Abstract][Full Text] [Related]
5. Changes in pulmonary function after three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, or proton beam therapy for non-small-cell lung cancer.
Lopez Guerra JL; Gomez DR; Zhuang Y; Levy LB; Eapen G; Liu H; Mohan R; Komaki R; Cox JD; Liao Z
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e537-43. PubMed ID: 22420964
[TBL] [Abstract][Full Text] [Related]
6. Accelerated hypofractionated magnetic resonance-guided adaptive radiotherapy for oligoprogressive non-small cell lung cancer.
La Rosa A; Mittauer KE; Chuong MD; Hall MD; Kutuk T; Bassiri N; McCulloch J; Alvarez D; Herrera R; Gutierrez AN; Tolakanahalli R; Mehta MP; Kotecha R
Med Dosim; 2023 Winter; 48(4):238-244. PubMed ID: 37330328
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary function decreases moderately after accelerated high-dose irradiation for stage III non-small cell lung cancer.
Grambozov B; Wolf F; Kaiser J; Wass R; Fastner G; Gaisberger C; Rettenbacher L; Studnicka M; Pirich C; Sedlmayer F; Zehentmayr F
Thorac Cancer; 2020 Feb; 11(2):369-378. PubMed ID: 31855325
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary function changes following helical tomotherapy in patients with inoperable, locally advanced non-small cell lung cancer.
Vekens K; Verbanck S; Collen C; Storme G; Barbé K; De Ridder M; Vanderhelst E
Strahlenther Onkol; 2020 Feb; 196(2):142-150. PubMed ID: 31300831
[TBL] [Abstract][Full Text] [Related]
9. Effects of radiotherapy and chemotherapy on lung function in patients with non-small-cell lung cancer.
Gopal R; Starkschall G; Tucker SL; Cox JD; Liao Z; Hanus M; Kelly JF; Stevens CW; Komaki R
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):114-20. PubMed ID: 12694829
[TBL] [Abstract][Full Text] [Related]
10. Hypofractionated Image-guided Radiation Therapy (3Gy/fraction) in Patients Affected by Inoperable Advanced-stage Non-small Cell Lung Cancer After Long-term Follow-up.
Agolli L; Valeriani M; Bracci S; Nicosia L; DE Sanctis V; Enrici RM; Osti MF
Anticancer Res; 2015 Oct; 35(10):5693-700. PubMed ID: 26408745
[TBL] [Abstract][Full Text] [Related]
11. High-dose accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in locally advanced non-small-cell lung cancer: a feasibility study.
Liu YE; Lin Q; Meng FJ; Chen XJ; Ren XC; Cao B; Wang N; Zong J; Peng Y; Ku YJ; Chen Y
Radiat Oncol; 2013 Aug; 8(1):198. PubMed ID: 23937855
[TBL] [Abstract][Full Text] [Related]
12. Changes in Pulmonary Function Following Image-Guided Stereotactic Lung Radiotherapy: Neither Lower Baseline Nor Post-SBRT Pulmonary Function Are Associated with Worse Overall Survival.
Stone B; Mangona VS; Johnson MD; Ye H; Grills IS
J Thorac Oncol; 2015 Dec; 10(12):1762-9. PubMed ID: 26334751
[TBL] [Abstract][Full Text] [Related]
13. Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer.
Hasselle MD; Haraf DJ; Rusthoven KE; Golden DW; Salgia R; Villaflor VM; Shah N; Hoffman PC; Chmura SJ; Connell PP; Vokes EE; Weichselbaum RR; Salama JK
J Thorac Oncol; 2012 Feb; 7(2):376-81. PubMed ID: 22198429
[TBL] [Abstract][Full Text] [Related]
14. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers.
Onimaru R; Shirato H; Shimizu S; Kitamura K; Xu B; Fukumoto S; Chang TC; Fujita K; Oita M; Miyasaka K; Nishimura M; Dosaka-Akita H
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):126-35. PubMed ID: 12694831
[TBL] [Abstract][Full Text] [Related]
15. A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy.
Grills IS; Hope AJ; Guckenberger M; Kestin LL; Werner-Wasik M; Yan D; Sonke JJ; Bissonnette JP; Wilbert J; Xiao Y; Belderbos J
J Thorac Oncol; 2012 Sep; 7(9):1382-93. PubMed ID: 22843086
[TBL] [Abstract][Full Text] [Related]
16. Image guided hypofractionated 3-dimensional radiation therapy in patients with inoperable advanced stage non-small cell lung cancer.
Osti MF; Agolli L; Valeriani M; Falco T; Bracci S; De Sanctis V; Enrici RM
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e157-63. PubMed ID: 23182393
[TBL] [Abstract][Full Text] [Related]
17. Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable Stage I nonsmall cell lung carcinomas.
Fukumoto S; Shirato H; Shimzu S; Ogura S; Onimaru R; Kitamura K; Yamazaki K; Miyasaka K; Nishimura M; Dosaka-Akita H
Cancer; 2002 Oct; 95(7):1546-53. PubMed ID: 12237924
[TBL] [Abstract][Full Text] [Related]
18. First 500 Fractions Delivered with a Magnetic Resonance-guided Radiotherapy System: Initial Experience.
Sahin B; Zoto Mustafayev T; Gungor G; Aydin G; Yapici B; Atalar B; Ozyar E
Cureus; 2019 Dec; 11(12):e6457. PubMed ID: 32025388
[TBL] [Abstract][Full Text] [Related]
19. Dose escalation of accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in unresectable stage III non-small-cell lung cancer: a phase I trial.
Lin Q; Liu YE; Ren XC; Wang N; Chen XJ; Wang DY; Zong J; Peng Y; Guo ZJ; Hu J
Radiat Oncol; 2013 Aug; 8(1):201. PubMed ID: 23957889
[TBL] [Abstract][Full Text] [Related]
20. Impact of 3D conformal radiotherapy on lung function of patients with lung cancer: a prospective study.
Enache I; Noel G; Jeung MY; Meyer N; Oswald-Mammosser M; Pistea C; Jung GM; Mennecier B; Quoix E; Charloux A
Respiration; 2013; 86(2):100-8. PubMed ID: 23154264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
